drugset / Trial / NCT01718951
Golimumab Versus Pamidronate for the Treatment of Axial Spondyloarthropathy: a 48-week Trial
RandomizedParallel-groupOpen-labelTreatment
Summary
To compare the efficacy of golimumab with pamidronate in the treatment of axial spondyloarthropathy
Timeline
- Start
- 2012-08
- Primary completion
- 2014-03
- Completion
- 2014-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Golimumab | Monoclonal antibody | 50 mg | Subcutaneous |
| Comparator | Pamidronate | Small molecule | 60 mg | Intravenous |